# QWN · Stent Graft, Infrapopliteal, Venous Arterialization

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/CV-misc/QWN

## Overview

- **Product Code:** QWN
- **Device Name:** Stent Graft, Infrapopliteal, Venous Arterialization
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)
- **Implant:** yes
- **Life-sustaining:** yes

## Identification

For performing percutaneous arterialization of the deep veins to restore blood flow in the lower limbs

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P220025](https://fda.innolitics.com/submissions/CV/CV-misc/QWN/P220025.md) | LimFlow System | LimFlow, Inc. | Sep 11, 2023 | APPR |

## Top Applicants

- LimFlow, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/submissions/CV/CV-misc/QWN](https://fda.innolitics.com/submissions/CV/CV-misc/QWN)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com